A novel approach for Deep Proteomic Insight Across different biofluids
Human body fluids provide a rich source of information that can be used to predict a patient’s disease state and guide drug development or personalized therapies.
In this webinar we show how the combination of the Proteograph Product Suite and high-end mass spectrometry provides unbiased access to thousands of proteins that have not been detectable by conventional proteomics techniques.
For the first time we present unique insight into Evotec’s benchmark data set on human serum, plasma, cerebrospinal fluid (CSF), urine and cell secretome. Learn more about Evotec's Clinical Proteomics offering here.
Speakers
|
|
Carleen Kluger Group Leader Clinical Proteomics, Mass Spectrometry Carleen Kluger's scientific specialty is the mechanics of protein-protein interaction, both at single molecule but also cell level. She joined Evotec’s mass spectrometry department as a bioinformatician in 2019 and is currently leading the Clinical Proteomics Group. Carleen was trained in physics at University of Munich (LMU) and graduated from the Max Planck Institute of Biochemistry with a thesis on intracellular mechanotransduction. |
|
|
Daniel Hornburg VP, Proteomics at Seer Vice President and scientific leader in precision omics, developing and integrating mass spec-based multi-omics solutions to characterize the proteome, metabolome as well as lipidome and dissect molecular big data with tailored machine-learning strategies. Daniel earned his PhD at the Max Planck Institute and graduated from the Technical University Munich with a Master of Science in Molecular Biotechnology. |
